{
  "scores": {
    "rubric_version": "v3.0-2025-10-14",
    "items": {
      "Title": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Trial_Design": {
        "score": 1,
        "evidence": "Participants will be randomised into two surgical groups (RIMA-SVG vs Ao-SVG)."
      },
      "Participants": {
        "score": 2,
        "evidence": "This non-inferiority, single-centre, prospective, double-blind, randomised clinical trial will enrol 300 patients undergoing CABG."
      },
      "Intervention": {
        "score": 2,
        "evidence": "Participants will be randomised into two surgical groups (RIMA-SVG vs Ao-SVG)."
      },
      "Objective": {
        "score": 1,
        "evidence": "This study aims to determine whether the RIMA-SVG technique is non-inferior to the conventional Aorta (Ao)-SVG approach in terms of 1-year graft patency, while also comparing perioperative complications and short-term clinical outcomes."
      },
      "Method_Outcome": {
        "score": 2,
        "evidence": "The primary outcome is the 1-year SVG patency rate, assessed using coronary CT angiography."
      },
      "Randomisation_Allocation": {
        "score": 2,
        "evidence": "Randomisation will be computer-generated, and all procedures will be performed by experienced surgeons."
      },
      "Blinding": {
        "score": 2,
        "evidence": "double-blind"
      },
      "Number_Randomised": {
        "score": 1,
        "evidence": "This non-inferiority, single-centre, prospective, double-blind, randomised clinical trial will enrol 300 patients undergoing CABG."
      },
      "Number_Analysed": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Result_Outcome": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Harms": {
        "score": 1,
        "evidence": "Secondary outcomes include perioperative complications, all-cause mortality, major adverse cardiovascular and cerebrovascular events (MACCE), and surgical site infections occurring during hospitalisation and up to 1 year postoperatively."
      },
      "Trial_Registration": {
        "score": 1,
        "evidence": "registered at ClinicalTrials.gov ( NCT06787651 )"
      },
      "Funding": {
        "score": 0,
        "evidence": "Not reported"
      }
    },
    "total_score": 15,
    "max_score": 25
  },
  "model": "gpt-4o"
}